39 items found for "Exscientia"
- Exscientia is 10 years old this July!
July 2022 "Today we are celebrating ten years of Exscientia! Founded as a spinout from the University of Dundee on 20 July 2012, Exscientia pioneered the design of We’re excited about delivering the next ten years of Exscientia and advancing AI to design better drugs
- Exscientia welcomes Richard J. Law, as their new Chief Business Officer
Richard is the architect behind nearly all of Exscientia's partnerships and collaborations across pharma
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
., of the University of Oxford, has joined Exscientia as Chief Scientist of Biologics AI. Professor Deane joins Exscientia’s technology leadership team, reporting to Chief Technology Officer, She will maintain both of these roles, in addition to her role at Exscientia.
- 21-08 Dr GPCR Newsletter
Industry news Exscientia establishes an internal pre-clinical development group in Oxford, UK. Maria Dominguez joins as VP, Head of Pre-clinical team Bristol Myers Squibb exercises option to develop Exscientia registration and alert facility on their Careers page Sosei Heptares announces their SARS-CoV-2 MPro Progam Exscientia Barros-Álvarez, and Ryan Knihtila to the team Addex announced our half-year and second-quarter financial results Exscientia
- 22-01 Dr GPCR Newsletter
Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI Oxford Professor of Chemistry $4-bil market opportunity in dyskinesia Verily links up with Sosei Heptares for GPCR drug discovery Exscientia
- 21-03 Dr GPCR Newsletter
Industry news Exscientia completes $100 million Series C financing round with BlackRock funds Exscientia